Dr. Anthony Magliocco has had a career spanning over 30 years and is an internationally recognized expert in developing and deploying advanced diagnostics to help cancer patients.

Prior to founding Protean Bio diagnostics, Dr. Magliocco was chair of Pathology and Executive Director of Esoteric Laboratory Services at Moffitt Cancer Center. In addition, he served as Scientific Director of Moffitt Cancer Center Tissue Core and founded new fellowships in molecular diagnostics as well as digital image analysis.

Dr. Magliocco has published over 200 manuscripts, which have been cited over times 10,000 times in the scientific literature.

We're going to be talking about the evolving role of the pathologist in the setting of personalized medicine.

What has pathology, as a field, done well, in terms of providing tools and solutions to assist clinicians and patients in individualizing treatment options?

What opportunities are there for change or improvement amidst, the massive growth and opportunity in the field of personalized medicine. Will our expanding capabilities in image analysis and the promise of artificial intelligence enable us to create new and powerful tools to diagnose disease and guide therapy?

Have we finally turned the corner in incorporating diagnostics two large prospective randomized trials which will allow us to develop and validate powerful tools to refine our prognostic and predictive capabilities? Does image analysis and the ability to Multiplex open up a whole new world of possibilities to create more powerful tools than we ever imagined? And what does the future hold?